Android app Apple app link

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability

By Yahoo! Finance   |   4 weeks ago
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability

Analysing Avadel Pharmaceuticals plc (NASDAQ:AVDL) reveals potential for significant growth, with analysts predicting breakeven in 2025 and a 48% growth rate. High debt levels pose a risk, but the company's future looks promising in the biopharmaceutical industry.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.